Novartis AG Total Liabilities 2010-2025 | NVS

Novartis AG total liabilities for the quarter ending March 31, 2025 were $61.489B, a 12.66% increase year-over-year.

  • Novartis AG total liabilities for 2024 were $58.12B, a 9.26% increase from 2023.
  • Novartis AG total liabilities for 2023 were $53.195B, a 8.33% decline from 2022.
  • Novartis AG total liabilities for 2022 were $58.03B, a 9.29% decline from 2021.

Novartis AG Total Liabilities 2010-2025 | NVS

  • Novartis AG total liabilities for 2024 were $58.12B, a 9.26% increase from 2023.
  • Novartis AG total liabilities for 2023 were $53.195B, a 8.33% decline from 2022.
  • Novartis AG total liabilities for 2022 were $58.03B, a 9.29% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B